Notable Labs, Ltd.
Notable Labs, Ltd. (NTBL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NTBL · as of Jun 9, 2026
Key Statistics
Explore Notable Labs, Ltd. Data
ntbl stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
Competitors & Peers
ntbl competitorsNTBL
ARAV
ATNX
BPTS
EIGRQ
FRESStock Performance
Full HistoryAbout Notable Labs, Ltd.
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Pre…
what is notable labs, ltd. · ntbl stock overview · notable labs, ltd. company profile · who is notable labs, ltd. ceo · ntbl NASDAQ · notable labs, ltd. headquarters · notable labs, ltd. business segments
About Stock Overview & Key Data
Notable Labs, Ltd. (NTBL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 1, 2014. As of the latest trading session, NTBL stock price is $0.25, with a market capitalization of $2.4M. The stock has returned -93.44% over the past 12 months and -86.53% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Notable Labs, Ltd. stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, Notable Labs, Ltd. reported revenue of $310000.00 and net income of -$11.3M. For detailed data — including Notable Labs, Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Notable Labs, Ltd. (NTBL) stock price is $0.25. The stock is traded on NASDAQ under the ticker symbol NTBL. The 52-week range is $0.22 – $4.24.